Aquestive Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.10 | -$0.08 | -$0.09 |
| Q2 2024 | 1 | -$0.13 | -$0.10 | -$0.12 |
| Q3 2024 | 1 | -$0.13 | -$0.10 | -$0.12 |
| Q4 2024 | 4 | -$0.14 | -$0.12 | -$0.13 |
| Q1 2025 | 4 | -$0.15 | -$0.11 | -$0.13 |
| Q2 2025 | 2 | -$0.15 | -$0.12 | -$0.13 |
| Q3 2025 | 2 | -$0.15 | -$0.12 | -$0.13 |
| Q4 2025 | 2 | -$0.15 | -$0.12 | -$0.13 |
Aquestive Therapeutics, Inc. Earnings Date And Information
Aquestive Therapeutics, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-0.13 earnings per share for the quarter, missing analysts' consensus estimates of $-0.12 by $0.01. The company had revenue of 13.54 M for the quarter and had revenue of 50.58 M for the year. Aquestive Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.13 diluted earnings per share) and currently has a price-to-earnings ratio of -11.36. Aquestive Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Aquestive Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | -$0.12 | -$0.13 | -0.01 | $12.69 M | $13.54 M |
| 08/06/2024 | Q2 2024 | -$0.11 | -$0.03 | 0.08 | $12.39 M | $20.10 M |
| 05/07/2024 | Q1 2024 | -$0.09 | -$0.17 | -0.08 | $12.05 M | |
| 03/05/2024 | Q4 2023 | -$0.08 | -$0.12 | -0.04 | $13.21 M | |
| 11/06/2023 | Q3 2023 | -$0.11 | -$0.03 | 0.08 | $11.51 M | $13.00 M |
| 08/07/2023 | Q2 2023 | -$0.11 | -$0.10 | 0.01 | $11.01 M | $13.24 M |
| 05/02/2023 | Q1 2023 | -$0.10 | $0.35 | 0.45 | $11.13 M | |
| 03/31/2023 | Q4 2022 | -$0.33 | $10.68 M | |||
| 11/01/2022 | Q3 2022 | -$0.30 | -$0.23 | 0.07 | $11.00 M | $11.46 M |
| 08/02/2022 | Q2 2022 | -$0.41 | -$0.44 | -0.03 | $10.57 M | $13.27 M |
| 05/03/2022 | Q1 2022 | -$0.40 | $12.27 M | |||
| 03/08/2022 | Q4 2021 | -$0.37 | -$0.72 | -0.35 | $11.08 M | |
| 11/02/2021 | Q3 2021 | -$0.40 | -$0.37 | 0.03 | $11.01 M | $13.29 M |
| 08/03/2021 | Q2 2021 | -$0.42 | -$0.33 | 0.09 | $9.48 M | $15.35 M |
| 05/04/2021 | Q1 2021 | -$0.44 | -$0.41 | 0.03 | $11.12 M | |
| 03/09/2021 | Q4 2020 | -$0.46 | -$0.60 | -0.14 | $7.15 M | |
| 11/04/2020 | Q3 2020 | -$0.50 | -$0.49 | 0.01 | $8.72 M | $8.26 M |
| 08/04/2020 | Q2 2020 | -$0.43 | -$0.07 | 0.36 | $8.77 M | $21.68 M |
| 05/05/2020 | Q1 2020 | -$0.52 | -$0.49 | 0.03 | $8.77 M | |
| 03/11/2020 | Q4 2019 | -$0.45 | -$0.48 | -0.03 | $16.42 M |
Aquestive Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Aquestive Therapeutics, Inc.'s earnings date?
Aquestive Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
-
How can I listen to Aquestive Therapeutics, Inc.'s earnings conference call?
The conference call for Aquestive Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Aquestive Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Aquestive Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Aquestive Therapeutics, Inc. generate each year?
Aquestive Therapeutics, Inc. (:AQST) has a recorded annual revenue of $50.58 M.
-
How much profit does Aquestive Therapeutics, Inc. generate each year?
Aquestive Therapeutics, Inc. (:AQST) has a recorded net income of $50.58 M. Aquestive Therapeutics, Inc. has generated $-0.13 earnings per share over the last four quarters.
-
What is Aquestive Therapeutics, Inc.'s price-to-earnings ratio?
Aquestive Therapeutics, Inc. (:AQST) has a price-to-earnings ratio of -11.36 and price/earnings-to-growth ratio is 0.4.
